Why we built antevel

The signals that show where research is heading, funded grants, registered trials, preprints and new datasets, are public, but scattered across databases nobody reads together. We kept tracking them by hand, and knew a biotech or a team needed one place to watch a field forming.

So we built antevel: more context on the research around you, the collaborators forming around a topic, the adjacent ideas worth exploring, and a real way to quantify how much interest is building in a field, all upstream of publication.

The people behind antevel

Two co-founders building the upstream watch on scientific research, upstream of publication.

Marcos Bolaños

Marcos Bolaños

Co-founder & CEO

AI and bio. Works on machine learning, including molecule-generation models.

Pierre Natiez

Pierre Natiez

Co-founder & CTO

Software engineer in bioinformatics, building tools for life science research.

Biotech only moves as fast as teams can keep up with their own field. We are building antevel to make that pace feel manageable.

AI is going to accelerate research, so even more papers and work will come out than today. Someone has to help teams keep up with all of it.

Marcos BolañosCo-founder & CEO
Pierre NatiezCo-founder & CTO

Let's talk about what's next

antevel is a small, independent team. Partnership, collaboration, an opportunity, or simply an idea to share, we are open to it all and we read everything.

Marcos Bolaños
Pierre Natiez

Straight from the founders

PubMed
OpenAlex
arXiv
Perplexity
Zenodo
NIH
arXiv
Perplexity
Zenodo
NIH
PubMed
OpenAlex

See your field forming,
upstream of publication

Try antevel now